|
1
|
Claus S, Weiler C, Schiewe J and Friess W:
How can we bring high drug doses to the lung? J Pharm Biopharm.
86:1–6. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yang MY, Chan JG and Chan HK: Pulmonary
drug delivery by powder aerosols. J Control Rel. 193:228–240.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tonnis WF, Lexmond AJ, Frijlink HW, de
Bore AH and Hinrichs WL: Devices and formulations for pulmonary
vaccination. Expert Opin Drug Deliv. 10:1383–1397. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bouwmeester C, Kraft J and Bungay KM:
Optimizing inhaler use by pharmacist-provided education to
community-dwelling elderly. Respir Med. 109:1363–1368.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Broeders ME, Vincken W, Corbetta L and
Group AW: The ADMIT series-Issues in inhalation therapy. 7. Ways to
improve pharmacological management of COPD: The importance of
inhaler choice and inhalation technique. Prime Care Respir J.
20:338–343. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cochrane MG, Bala MV, Downs KE, Mauskopf J
and Ben-Joseph RH: Inhaled corticosteroids for asthma therapy:
Patient compliance, devices, and inhalation technique. Chest.
117:542–550. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Baily MM, Gorman EM, Munson EJ and
Berkland C: Pure insulin nanoparticle agglomerates for pulmonary
delivery. Lungmuir. 24:13614–13620. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Weer JG and Miller DP: Formulation design
of dry powders for inhalation. J Pharm Sci. 104:3259–3288.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Stocks J and Hislop AA: Structure and
function of the respiratory system: Developmental aspects and their
relevance to aerosol therapy. In: Drug Delivery to the Lung:
Clinical Aspects. Bisgaard H, O'Callaghan C, Smaldone CG (eds.)
Marcel Dekker, Inc., New York, NY pp47-104, 2002.
|
|
10
|
Lavorini F, Pistolesi M and Usmani OS:
Recent advances in capsule-based dry powder inhaler technology.
Multidiscip Respir Med. 12(11)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Berkenfeld K, Lamprecht A and McConville
JT: Devices for dry powder drug delivery to the lung. AAPS
PharmSciTech. 16:479–490. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Faulhammer E, Flink M, Liusa M, Lawrence
SM, Biserni S, Calzolari V and Khinast JG: Low-dose capsule filling
of inhalation products: Critical material attributes and process
parameters. Int J Pharm. 473:617–626. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wauthoz N, Hennia I, Dejaeger B, Ecenarro
S and Amighi K: Proposed algorithm for healthcare professionals
based on product characteristics and in vitro performances in
different use conditions using formoterol-based marketed products
for inhalation. Int J Pharm. 530:415–429. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Smith IJ, Bell J, Bowman N, Everard M,
Stein S and Weer JG: Inhaler devices: What remains to be done? J
Aerol Med Pulm Drug Deliv. (Suppl 2):S25–S37. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Steckel H and Muller BW: In-vitro
evaluation of dry powder inhalers 1: Drug deposition of commonly
used devices. Int J Phar. 154:19–29. 1997.
|
|
16
|
Vidgren M, Kärkkäinen A, Karjalainen P,
Paronen P and Nuutinen J: Effect of powder inhaler design on drug
deposition in the respiratory tract. Int J Pharm. 42:211–216.
1988.
|
|
17
|
Chew NY, Shekunov BY, Tong HH, Chow AH,
Savage C, Wu J and Chan H: Effect of amino acids on the dispersion
of disodium cromoglycate powders. J Pharm Sci. 94:2289–2300.
2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Otake H, Okuda T and Okamoto H:
Development of spray-freeze dried powders for inhalation with high
inhalation performance and antihygroscopic property. Chem Pharm
Bull (Tokyo). 64:239–245. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li HY, Seville PC, Williamson IJ and
Birchall JC: The use of amino acids to enhance the aerosolisation
of spray-dried powders for pulmonary gene therapy. J Gene Med.
7:343–353. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Ungaro F, Giovino C, Coletta C, Sorrentino
R, Miro A and Quaglia F: Engineering gas-foamed large porous
particles for efficient local delivery of macromolecules to the
lung. Eur J Pharm Sci. 41:60–70. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Duan J, Vogt FG, Li X, Hayes Jr D and
Mansour HM: Design, characterization, and aerolization of organic
solution advanced spray-dried moxifloxacin and ofloxacin
dipalmitoylphosphatidylcholine (DPPC)
microparticulate/nanoparticulate powders for pulmonary inhalation
aerosol delivery. Int J Nanomedicine. 8:3489–3505. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wauthoz N, Hennia I, Ecenarro S and Amighi
K: Impact of capsule type on aerodynamic performance of inhalation
products: A case study using a formoterol-lactose binary or ternary
blend. Int J Pharm. 553:47–56. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Saleem IY, Diez F, Jones BE and Polo L:
Investigation on the aerosol performance of dry powder inhalation
hypromellose capsules with different lubricant levels. Int J Pharm.
492:258–263. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Horhota ST, van Noord JA, Verkleij CB,
Bour LJ, Sharma A, Trunk M and Cornelissen PJ: In vitro,
pharmacokinetic, pharmacodynamic, and safety comparisons of single
and combined administration of Tiotropium and Salmeterol in COPD
patients using different dry powder inhalers. AAPS J. 17:871–880.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hira D, Koide H, Nakamura S, Okada T,
Ishizeki K, Yamaguchi M, Koshiyama S, Oguma T, Ito K, Funayama S,
et al: Assessment of inhalation flow patterns of soft mist inhaler
co-prescribed with dry powder inhaler using inspiratory flow meter
for multi inhalation devices. PLoS One. 13(e0193082)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
García R and Pérez R: Dynamic atomic force
microscopy methods. Surf Sci Rep. 47:197–301. 2002.
|
|
27
|
Nagata S: Gellulose capsules-an
alternative to gelatin. In: Biolodical Polymers and Polymer
Therapeutics. Chiellini E, Sunamoto J, Migliaresi C, Ottenbrite RM,
Cohn D (eds). Kluwer Academics/Plenum Publishers, New York, NY, pp
53-62, 2001.
|
|
28
|
Coate MS, Fletcher DF, Chan HK and Raper
JA: The role of capsule on the performance of a dry powder inhaler
using computational and experimental analysis. Pharm Res.
22:923–932. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mehta PP, Kadam SS and Pawar AP: Effect of
USP induction ports and modified glass sampling apparatus on
aerosolization performance of lactose carrier-based fluticasone
propionate dry powder inhaler. J Drug Deliv Sci Technol.
58(101794)2020.
|
|
30
|
Timsina MP, Martin GP, Marriott C,
Ganderton D and Yianneskis M: Drug delivery to the respiratory
tract using dry powder inhalers. Int J Pharm. 101:1–13. 1994.
|
